Posted On: 12/15/2015 6:06:54 PM
Post# of 193
Valeant Strongly Bullish, 20% Intraday Gain
As a consequence of positive developments with the company and in anticipation of VRX Investor Day on Dec 16, Valeant Pharmaceuticals shares rallied 20% on intraday high.
The stock is strongly bullish and we can anticipate bull run to continue.
In another news, Citron Research admitted defeat on Twitter. Andrew Left twitted that he is happy that company is now dealing with Walgreen for its prescriptions. He also said he is happy that one person could change the company for the positive. In a way, he admitted defeat. Valeant shares are up 50% since Nov 11 low.
Make sure to tune in for another bullish day on Wednesday Dec 16, VRX Investor Day!
As a consequence of positive developments with the company and in anticipation of VRX Investor Day on Dec 16, Valeant Pharmaceuticals shares rallied 20% on intraday high.
The stock is strongly bullish and we can anticipate bull run to continue.
In another news, Citron Research admitted defeat on Twitter. Andrew Left twitted that he is happy that company is now dealing with Walgreen for its prescriptions. He also said he is happy that one person could change the company for the positive. In a way, he admitted defeat. Valeant shares are up 50% since Nov 11 low.
Make sure to tune in for another bullish day on Wednesday Dec 16, VRX Investor Day!
(0)
(0)
